OBJECTIVE: To assess the influence of diabetic neuropathy (DN) on balance and functional strength in patients with diabetes mellitus type 2 (DM2). DESIGN: Cross-sectional study. SETTING: Diabetes outpatient unit. PARTICIPANTS: Adults (N=62; age range, 40-65y): 32 with DM2 (19 subjects without DN and 13 with DN) and 30 without DM2 (control group). INTERVENTIONS: Not applicable. MAIN OUTCOME MEASURES: Upright balance, evaluated in 4 situations (fixed platform, unstable platform, with eyes open, with eyes closed), and functional strength, assessed with a five-times-sit-to-stand test, were analyzed using an electromagnetic system, with a sensor placed over C7 to allow maximum trunk displacements in the anterior-posterior and medial-lateral directions. The Berg Balance Scale and the Timed Up & Go test were also used. RESULTS: Subjects with DM2 had greater anterior-posterior displacement (P<.05) in the unstable platform with eyes closed condition compared with those without DM2, whereas no difference in medial-lateral displacement was observed between these groups. A difference in time was observed in the five-times-sit-to-stand test (P<.05), with subjects in the control group performing the tasks faster than either group of subjects with DM2. Additionally, subjects in the control group showed a higher score in the Berg Balance Scale and performed the Timed Up & Go test in less time compared with subjects in other groups. CONCLUSIONS: Subjects with DM2, with or without DN, showed deficits in postural control and functional strength compared with healthy individuals of the same age group.
OBJECTIVE: To assess the influence of diabetic neuropathy (DN) on balance and functional strength in patients with diabetes mellitus type 2 (DM2). DESIGN: Cross-sectional study. SETTING:Diabetesoutpatient unit. PARTICIPANTS: Adults (N=62; age range, 40-65y): 32 with DM2 (19 subjects without DN and 13 with DN) and 30 without DM2 (control group). INTERVENTIONS: Not applicable. MAIN OUTCOME MEASURES: Upright balance, evaluated in 4 situations (fixed platform, unstable platform, with eyes open, with eyes closed), and functional strength, assessed with a five-times-sit-to-stand test, were analyzed using an electromagnetic system, with a sensor placed over C7 to allow maximum trunk displacements in the anterior-posterior and medial-lateral directions. The Berg Balance Scale and the Timed Up & Go test were also used. RESULTS: Subjects with DM2 had greater anterior-posterior displacement (P<.05) in the unstable platform with eyes closed condition compared with those without DM2, whereas no difference in medial-lateral displacement was observed between these groups. A difference in time was observed in the five-times-sit-to-stand test (P<.05), with subjects in the control group performing the tasks faster than either group of subjects with DM2. Additionally, subjects in the control group showed a higher score in the Berg Balance Scale and performed the Timed Up & Go test in less time compared with subjects in other groups. CONCLUSIONS: Subjects with DM2, with or without DN, showed deficits in postural control and functional strength compared with healthy individuals of the same age group.
Authors: Elaine Caldeira de Oliveira Guirro; Rinaldo Roberto de Jesus Guirro; Almir Vieira Dibai-Filho; Thais Montezuma; Maíta Mara de Oliveira Lima Leite Vaz Journal: J Phys Ther Sci Date: 2014-04-23
Authors: Cid André Fidelis de Paula Gomes; Ernesto Cesar Pinto Leal-Junior; Daniela Aparecida Biasotto-Gonzalez; Yasmin El-Hage; Fabiano Politti; Tabajara de Oliveira Gonzalez; Almir Vieira Dibai-Filho; Adriano Rodrigues de Oliveira; Marcelo Frigero; Fernanda Colella Antonialli; Adriane Aver Vanin; Paulo de Tarso Camillo de Carvalho Journal: Trials Date: 2014-04-09 Impact factor: 2.279
Authors: Tessa Riandini; Hwee Lin Wee; Eric Y H Khoo; Bee Choo Tai; Wilson Wang; Gerald C H Koh; E Shyong Tai; Subramaniam Tavintharan; Kurumbian Chandran; Siew Wai Hwang; Kavita Venkataraman Journal: Acta Diabetol Date: 2017-11-28 Impact factor: 4.280
Authors: Birgit L M Van Eetvelde; Dirk Cambier; Karsten Vanden Wyngaert; Bert Celie; Patrick Calders Journal: J Diabetes Res Date: 2018-11-29 Impact factor: 4.011